Ryan Bird

Ryan Bird has over 17 years of experience in the biopharmaceutical industry. In 2022, they began working as Senior Director, CMC at Marengo Therapeutics. Prior to that, they were Director, CMC Technical Program Leader at Rubius Therapeutics from 2021. From 2005 to 2021, they worked at Sanofi in various roles, including Associate Director, Global MSAT Analytical Science & Technology, Senior Manager, Global MSAT Analytical Science & Technology, Senior Analytical Scientist, Global MSAT Network Ops & Performance, Analytical Scientist, Process Analytics, Principal Analytical Development Associate, Process Analyics, Senior Analytical Development Associate, Analytical Development Associate, and Analytical Development Assistant.

Ryan Bird obtained a Master of Science degree in Molecular Biotechnology from Northeastern University in 2012 and a Bachelor of Science degree in Biochemistry from Worcester Polytechnic Institute in 2005.